EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Outcomes of Acute Ischemic Stroke in Patients with Hematological Malignancies

Aayushi Garg iD, Prasanna Eswaradass, Saurav Chopra

Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 09.03.2026 · 1-8

DOI: 10.1017/cjn.2025.10498 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, online erschienen am 09.03.2026. Verfasst von Aayushi Garg und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The University of Kansas Medical Centerhttps://ror.org/036c9yv20, Kansas City, KS, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose: There is limited evidence regarding the use of acute interventions and outcomes in patients with hematological malignancies presenting with acute ischemic stroke (AIS). In this study, we aimed to evaluate the outcomes of AIS in patients with hematological malignancies.

Methods

Hospitalizations with primary diagnosis of AIS were identified from the Nationwide Readmissions Database 2016–2018. Logistic regression was used to compare differences in acute stroke interventions and clinical outcomes. Survival analysis was used to evaluate recurrent AIS after discharge.

Results

There were 1,347,150 hospitalizations due to AIS (mean ± SD age 70.3 ± 14.1 years, female 50.2%). Of these, 11,863 (0.9%) had a concurrent diagnosis of hematological malignancy. Patients with malignancy were less likely to receive intravenous thrombolysis (tPA) but not mechanical thrombectomy (MT). Among different hematological malignancies, patients with acute leukemia and Hodgkin lymphoma had a higher likelihood of in-hospital mortality, as compared to patients without malignancy. However, among patients treated with tPA or MT, clinical outcomes were comparable between the groups. Risk of readmission due to recurrent ischemic stroke was similar between patients with and without malignancy (hazards ratio: 1.0, 95% CI: 0.9–1.1).

Conclusions

Patients with hematological malignancies are less likely to receive tPA but not MT; however, their use is not associated with increased harm. Patients with acute leukemias and Hodgkin lymphoma have an increased risk of in-hospital mortality, but the use of acute reperfusion therapies appears to attenuate this excess risk. Early risk of stroke recurrence is not different in patients with and without hematological malignancies.

Schlagwörter

Stichwörter der Autor:innen

Leukemialymphomareperfusionthrombectomy

Autor:innen und Institutionen

  • Department of Neurology, The University of Kansas Medical Centerhttps://ror.org/036c9yv20, Kansas City, KS, USA.
  • Department of Pathology, The University of Kansas Medical Center, Kansas City, KS, USA.

ORCID-Profile: Aayushi Garg

Zitieren

APA

Garg, A., Eswaradass, P., & Chopra, S. (2026). Outcomes of Acute Ischemic Stroke in Patients with Hematological Malignancies. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 1-8. https://doi.org/10.1017/cjn.2025.10498

Vancouver

Garg A, Eswaradass P, Chopra S. Outcomes of Acute Ischemic Stroke in Patients with Hematological Malignancies. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 2026:1-8. doi:10.1017/cjn.2025.10498

BibTeX
@article{Garg2026,
  author = {Garg, Aayushi and Eswaradass, Prasanna and Chopra, Saurav},
  title = {Outcomes of Acute Ischemic Stroke in Patients with Hematological Malignancies},
  journal = {Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques},
  year = {2026},
  pages = {1--8},
  doi = {10.1017/cjn.2025.10498}
}
Kostenlos starten →